Immune Side Effects Tied to Better SCLC Survival

By:
On:
In: Health & Fitness

Medbrief Immune-Related Adverse Events Associated With Better Survival Outcomes in Extensive-Stage Small Cell Lung Cancer TOPLINE: Immune-related adverse events (irAEs) were associated with significantly improved progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small cell lung cancer (SCLC) who received chemoimmunotherapy compared with that in those whoContinue Reading